The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Detection and characterization of carcinoma cells in the blood
Open accessAbstract
A highly sensitive assay combining immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis has been developed to detect, enumerate, and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood. Peripheral blood (10–20 ml) from 30 patients with carcinoma of the breast, from 3 patients with prostate cancer, and from 13 controls was examined by flow cytometry for the presence of circulating epithelial cells defined as nucleic acid + , CD45 − , and cytokeratin + . Highly significant differences in the number of circulating epithelial cells were found between normal controls and patients with cancer including 17 with organ-confined disease. To determine whether the circulating epithelial cells in the cancer patients were neoplastic cells, cytospin preparations were made after immunomagnetic enrichment and were analyzed. Epithelial cells from patients with breast cancer generally stained with mAbs against cytokeratin and 3 of 5 for mucin-1. In contrast, no cells that stained for these antigens were observed in the blood from normal controls. The morphology of the stained cells was consistent with that of neoplastic cells. Of 8 patients with breast cancer followed for 1–10 months, there was a good correlation between changes in the level of tumor cells in the blood with both treatment with chemotherapy and clinical status. The present assay may be helpful in early detection, in monitoring disease, and in prognostication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
A case of cancer in which cells similar to those in the tumours were seen in the blood after death
Ashworth, T. G. (1869) · Medical Entomology and Zoology · Cited by 842
Liotta, L. A., Kleinerman, J. I., & Saidel, G. M. (1974) · PubMed · Cited by 766
Cancer principles and practice of oncology
Kerin, M. J. (1997) · Surgical Oncology · doi:10.1016/s0960-7404(97)90012-8 · Cited by 739
Quantitation of cell shedding into efferent blood of mammary adenocarcinoma.
Butler, T. P., & Gullino, P. M. (1975) · PubMed · Cited by 528
Pantel, K., Schlimok, G., Braun, S., Kutter, D., Lindemann, F., Schaller, G., Funke, I., Izbicki, J. R., & Riethmuller, G. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.17.1419 · Cited by 503
Ross, A., Cooper, B., Lazarus, H., Mackay, W., Moss, T., Ciobanu, N., Tallman, M., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.2605 · Cited by 488
Fidler, I. J. (1973) · European Journal of Cancer (1965) · doi:10.1016/s0014-2964(73)80022-2 · Cited by 409
Gerhard, M., Juhl, H., Kalthoff, H., Schreiber, H. W., Wagener, C., & Neumaier, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.725 · Cited by 373
Pantel, K., Schlimok, G., Angstwurm, M., et al. (1994) · Journal of Hematotherapy · doi:10.1089/scd.1.1994.3.165 · Cited by 306
Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in Neuroblastoma
Moss, T. J., Reynolds, C. P., Sather, H. N., Romansky, S. G., Hammond, G. D., & Seeger, R. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101243240403 · Cited by 232
Hadfield, G. (1954) · BMJ · doi:10.1136/bmj.2.4888.607 · Cited by 215
Ghossein, R. A., Scher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F., & Rosai, J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1195 · Cited by 206
Gross, H. J., Verwer, B., Houck, D., Hoffman, R. A., & Recktenwald, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.537 · Cited by 198
Roth, M. S., Antin, J. H., Ash, R. C., Terry, V., Gotlieb, M., Silver, S., & Ginsburg, D. (1992) · Blood · doi:10.1182/blood.v79.1.276.276 · Cited by 146
Wheelock, Ε. F., Weinhold, K. J., & Levich, J. D. (1981) · Advances in cancer research · doi:10.1016/s0065-230x(08)60240-7 · Cited by 138
Meltzer, A. (1990) · Journal of Surgical Oncology · doi:10.1002/jso.2930430312 · Cited by 114
Stahel, R. A., Gilks, W. R., Lehmann, H., et al. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570704 · Cited by 110
Cancer dormancy: studies of the murine BCL1 lymphoma.
Uhr, J. W., Tucker, T. F., May, R. D., Siu, H., & Vitetta, E. S. (1991) · PubMed · Cited by 65
Self-citationTumor Dormancy and Cell Signaling. V. Regrowth of the BCL1 Tumor After Dormancy Is Established
Vitetta, E. S., Tucker, T. F., Racila, E. V., Huang, Y.-W., Marcheş, R., Lane, N., Scheuermann, R. H., Street, N. E., Watanabe, T., & Uhr, J. W. (1997) · Blood · doi:10.1182/blood.v89.12.4425 · Cited by 53
Self-citationRegulation of Tumor Angiogenesis by Organ-Specific Cytokines
Singh, R. K., & Fidler, I. J. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-61109-4_1 · Cited by 26
Cited by
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
“In contrast, CTCs represent intact, often viable, cells that can be purified from blood by virtue of physicochemical characteristics or cell surface molecules that distinguish them from normal blood cells (15).”
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Self-citationIsolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542
Isolation by Size of Epithelial Tumor Cells
Vona, G., Sabile, A., Louha, M., Sitruk, V., Romana, S., Schütze, K., Capron, F., Franco, D., Pazzagli, M., Vekemans, M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64706-2 · Cited by 1,069
Metadata
- Authors
- Racila, E., Euhus, D., Weiss, A. J., Rao, C., McConnell, J., Terstappen, L. W. M. M., & Uhr, J. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-04-14
- Volume
- 95
- Issue
- 8
- Pages
- 4589-4594
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2101818435
- Cited by
- 712
- References
- 21
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.